SUSAN LANCASTER: Open Payments
NPI 1003460262 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$116 in 7 payments from 6 companies in 2025. Trend: 2023 $15 · 2024 $261 · 2025 $116
Food & beverage: $116
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Aurinia Pharma U.S., Inc. | 1 | $19 |
| AKEBIA THERAPEUTICS INC | 1 | $18 |
| Calliditas Therapeutics US Inc. | 1 | $17 |
| Fresenius USA Marketing, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: JARDIANCE, LUPKYNIS, Vafseo, TARPEYO, VELPHORO, FARXIGA.
Industry payments across NJ — which companies pay providers there.
